MX2009008993A - Dispositivo para la administracion percutanea de bisoprolol. - Google Patents

Dispositivo para la administracion percutanea de bisoprolol.

Info

Publication number
MX2009008993A
MX2009008993A MX2009008993A MX2009008993A MX2009008993A MX 2009008993 A MX2009008993 A MX 2009008993A MX 2009008993 A MX2009008993 A MX 2009008993A MX 2009008993 A MX2009008993 A MX 2009008993A MX 2009008993 A MX2009008993 A MX 2009008993A
Authority
MX
Mexico
Prior art keywords
bisoprolol
application
skin
transdermal administration
administration
Prior art date
Application number
MX2009008993A
Other languages
English (en)
Inventor
Katsuhiro Okada
Kunihiro Minami
Yoshihiro Iwao
Shuichiro Yuasa
Kensuke Matsuoka
Original Assignee
Nitto Denko Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nitto Denko Corp filed Critical Nitto Denko Corp
Publication of MX2009008993A publication Critical patent/MX2009008993A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención se refiere a un dispositivo para la administración percutánea de bisoprolol que comprende un soporte y una capa adhesiva sensible a la presión que contiene bisoprolol, la cual está laminada sobre la superficie de el soporte, donde el valor máximo de la tasa de liberación de bisoprolol durante un período que va desde el momento inmediatamente posterior a la aplicación sobre la piel hasta que transcurre un lapso de 24 horas es de 30 µg/cm2/hora o menos; y donde la tasa de liberación de bisoprolol una vez transcurrido el lapso de 24 horas posteriores a la aplicación sobre la piel es de 10 µg/cm2/hora o menos. El dispositivo para administración percutánea de la presente invención reduce la irritación de la piel durante la aplicación, especialmente en el momento del desprendimiento, y con el cual se puede administrar de manera constante una cantidad con eficacia terapéutica o preventiva de bisoprolol a un organismo vivo.
MX2009008993A 2007-03-08 2008-03-06 Dispositivo para la administracion percutanea de bisoprolol. MX2009008993A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007059279 2007-03-08
PCT/JP2008/054022 WO2008108424A1 (ja) 2007-03-08 2008-03-06 ビソプロロール経皮投与デバイス

Publications (1)

Publication Number Publication Date
MX2009008993A true MX2009008993A (es) 2009-09-02

Family

ID=39738296

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009008993A MX2009008993A (es) 2007-03-08 2008-03-06 Dispositivo para la administracion percutanea de bisoprolol.

Country Status (15)

Country Link
US (1) US8703178B2 (es)
EP (1) EP2119437A4 (es)
JP (2) JP5707649B2 (es)
KR (1) KR20090118957A (es)
CN (2) CN103784425B (es)
AR (1) AR065610A1 (es)
AU (1) AU2008221861B2 (es)
BR (1) BRPI0807662A2 (es)
CA (1) CA2678424C (es)
IL (1) IL200378A0 (es)
MX (1) MX2009008993A (es)
NZ (1) NZ579240A (es)
RU (1) RU2440811C2 (es)
TW (1) TWI415636B (es)
WO (1) WO2008108424A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5058531B2 (ja) * 2005-09-09 2012-10-24 日東電工株式会社 ビソプロロール含有貼付製剤
JP4945228B2 (ja) * 2005-12-13 2012-06-06 日東電工株式会社 ビソプロロール含有貼付製剤
NZ579240A (en) 2007-03-08 2011-03-31 Nitto Denko Corp Device for the transdermal administration of bisoprolol
KR20110127215A (ko) 2009-02-18 2011-11-24 히사미쓰 세이야꾸 가부시키가이샤 경피 흡수 제제
CN102413821A (zh) 2009-05-01 2012-04-11 久光制药株式会社 经皮吸收型制剂
JP5776079B2 (ja) * 2010-02-26 2015-09-09 日東電工株式会社 ビソプロロール含有貼付製剤
CN104981528B (zh) 2013-02-01 2017-03-29 3M创新有限公司 压敏粘合剂组合物和包含该压敏粘合剂组合物的粘合剂制品
JP2015051947A (ja) * 2013-09-06 2015-03-19 日東電工株式会社 ビソプロロール含有貼付製剤およびその包装体

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5656286A (en) 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
JP2512565B2 (ja) 1989-10-13 1996-07-03 積水化学工業株式会社 貼付剤
US5508038A (en) * 1990-04-16 1996-04-16 Alza Corporation Polyisobutylene adhesives for transdermal devices
US5149719A (en) 1990-04-27 1992-09-22 Minnesota Mining And Manufacturing Company Composition for transdermal penetration of medicaments
JPH0813956B2 (ja) 1990-06-22 1996-02-14 積水化学工業株式会社 表面保護フィルムの製造方法
JP3355671B2 (ja) 1992-11-09 2002-12-09 旭化成株式会社 粘接着剤用組成物
JPH07330591A (ja) 1994-06-06 1995-12-19 Kanegafuchi Chem Ind Co Ltd 経皮吸収製剤
DE19512181C2 (de) 1995-03-31 2003-11-06 Hexal Pharma Gmbh Transdermales System mit Ramipril und/oder Trandolapril als ACE-Hemmer
WO1996040085A2 (en) 1995-06-07 1996-12-19 Noven Pharmaceuticals, Inc. Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures
JPH10152434A (ja) 1996-09-26 1998-06-09 Nitto Denko Corp 経皮吸収型製剤
US6313141B1 (en) * 1997-06-13 2001-11-06 Neurogen Corporation 2-aminoalkylaminoquinolines as dopamine D4 ligands
JP4119502B2 (ja) 1997-07-08 2008-07-16 埼玉第一製薬株式会社 新規な経皮吸収促進剤を含有する外用剤組成物
JP3930984B2 (ja) 1997-12-12 2007-06-13 日東電工株式会社 経皮吸収型製剤
US20040142024A1 (en) 1999-07-27 2004-07-22 Hisamitsu Pharmaceutical Co., Inc. Patch formulation for external use
CA2394506C (en) 1999-12-15 2006-06-27 Hisamitsu Pharmaceutical Co., Inc. Adhesive preparations
FR2807323A1 (fr) 2000-04-10 2001-10-12 Oreal Composition, notamment cosmetique, renfermant un steroide et un 2-alkyl alcanol ou un ester
DE10033853A1 (de) 2000-07-12 2002-01-31 Hexal Ag Transdermales therapeutisches System mit hochdispersem Siliziumdioxid
JP2002038114A (ja) 2000-07-26 2002-02-06 Aicello Chemical Co Ltd 粘着付与マスターバッチ及びこれを用いた粘着フィルム
JP4358978B2 (ja) 2000-09-05 2009-11-04 日東電工株式会社 経皮吸収製剤
JP2002187836A (ja) 2000-12-21 2002-07-05 Oishi Koseido:Kk 貼付剤
JP4478757B2 (ja) * 2002-04-19 2010-06-09 日東電工株式会社 ビソプロロール含有貼付剤
JP2004244585A (ja) 2003-02-17 2004-09-02 Nippon Shokubai Co Ltd 粘着剤組成物および粘着製品
JP4694967B2 (ja) * 2003-07-31 2011-06-08 久光製薬株式会社 貼付剤
US20070158227A1 (en) 2004-01-30 2007-07-12 Satoshi Amano Plaster enclosing packaging bag
JP4745747B2 (ja) 2004-08-12 2011-08-10 日東電工株式会社 フェンタニル含有貼付製剤
MX2007004315A (es) * 2004-10-08 2008-03-11 Noven Pharma Dispositivo para suministro transdermico de farmaco que incluye un respaldo oclusivo.
EP1847264B1 (en) 2005-01-31 2017-05-03 Hisamitsu Pharmaceutical Co., Inc. Bisoprolol patch
JP4782438B2 (ja) 2005-02-17 2011-09-28 日東電工株式会社 貼付製剤
JP2007059279A (ja) 2005-08-25 2007-03-08 Nissan Motor Co Ltd 電池筐体および組電池
JP5058531B2 (ja) * 2005-09-09 2012-10-24 日東電工株式会社 ビソプロロール含有貼付製剤
JP4945228B2 (ja) 2005-12-13 2012-06-06 日東電工株式会社 ビソプロロール含有貼付製剤
JP5015562B2 (ja) 2005-12-13 2012-08-29 日東電工株式会社 貼付製剤
NZ579240A (en) 2007-03-08 2011-03-31 Nitto Denko Corp Device for the transdermal administration of bisoprolol

Also Published As

Publication number Publication date
CN103784425A (zh) 2014-05-14
US8703178B2 (en) 2014-04-22
AU2008221861A1 (en) 2008-09-12
AU2008221861B2 (en) 2013-03-21
AR065610A1 (es) 2009-06-17
CN103784425B (zh) 2016-08-17
JP2013199486A (ja) 2013-10-03
TW200902090A (en) 2009-01-16
RU2009137122A (ru) 2011-04-20
JP5707649B2 (ja) 2015-04-30
CN101626761A (zh) 2010-01-13
US20100098747A1 (en) 2010-04-22
JP2008247899A (ja) 2008-10-16
WO2008108424A1 (ja) 2008-09-12
BRPI0807662A2 (pt) 2014-06-10
EP2119437A4 (en) 2013-07-03
IL200378A0 (en) 2010-04-29
TWI415636B (zh) 2013-11-21
EP2119437A1 (en) 2009-11-18
JP5870350B2 (ja) 2016-02-24
RU2440811C2 (ru) 2012-01-27
NZ579240A (en) 2011-03-31
KR20090118957A (ko) 2009-11-18
CA2678424A1 (en) 2008-09-12
CA2678424C (en) 2014-05-27

Similar Documents

Publication Publication Date Title
MX2009008993A (es) Dispositivo para la administracion percutanea de bisoprolol.
MX2009012273A (es) Dispositivos de suministro transd?rmico que aseguran la liberaci?n mejorada de un principio activo a trav?s de una interfaz biol?gica.
WO2006041907A3 (en) Transdermal delivery of estradiol
WO2013036513A3 (en) Medical bandages with a skin adhesion reducing material
NO20050472L (no) Forbedret transdermalt leveringssystem for administrering av rotigotin
GB0606661D0 (en) Improvements relating to dressings
WO2005082428A3 (de) Pflaster mit reduzierter hautirritation
WO2008133982A3 (en) Adhesive patch with aversive agent
WO2008121765A8 (en) System for surgical drain fixation
WO2005094526A3 (en) Transdermal delivery device
BRPI0820581A8 (pt) Dispositivo de interface com paciente, e, cânula nasal
UA84303C2 (ru) Система для трансдермальной доставки лечебного средства
MX2019011434A (es) Dispositivo de aseguramiento de cateter con ventana.
WO2007044647A3 (en) Pressure bandage with medication delivery system
ATE460913T1 (de) Wundverband
WO2011029948A3 (de) Transdermales therapeutisches system zur verabreichung von fentanyl oder einem analogstoff davon
BRPI0417437A (pt) dispositivo para inibição da absorção, dispositivo para remoção de agente fisiologicamente ativo e dispositivo para redução do efeito de overdose
NZ611920A (en) Percutaneous absorption preparation containing rivastigmine
TW200738287A (en) Nicotine transdermal delivery system
WO2005067499A3 (en) Method and device for topical delivery of therapeutic agents to the skin
WO2011081810A3 (en) Packaged medical adhesive composite and method of delivering the composite
WO2008105038A1 (ja) 抗真菌症用貼付剤
WO2009026135A3 (en) Controlled transdermal bisoprolol delivery system
WO2016149077A3 (en) Fentanyl transdermal delivery system
WO2002017928A3 (de) Transdermales therapeutisches system zur abgabe von exemestan